Low rate of achieving LDL-cholesterol objective in a low income population;A baixa taxa de obtenção da meta do LDL-colesterol numa população de baixa renda

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue 3, 2005, Pages 162-165

  Vacanti, Luciano Janussi ^a,c   De Moraes Santos, Silvio C ^b   Fujita, Alessandro M ^b   Lima, David S ^b   Lopes, Alan F ^b   Vetorazi, Rodrigo ^b   Sellera, Ana ^b   Scarin, Nataly R ^b  

^a Instituto do Coração do Distrito Federal InCor DF   (Brazil)

^b Guilherme Álvaro Hospital   (Brazil)

^c SQSW   (Brazil)

Author keywords

Coronary artery disease; Dyslipidemia; Hypolipidemic therapy; LDL cholesterol

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAZIL; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; LIPID BLOOD LEVEL; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY;

EID: 25144523067     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2005001600003     Document Type: Article

References (14)

1. DATASUS - http://www.datasus.gov.br/DepartamentodeInformática do SUS. Ministério da Saúde. Governo do Brasil.
2. The Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronay events. Final report of the pooling project. J Chronic Dis 1978; 31: 201-306.
3. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. III Diretrizessobre Dislipidemiase Diretrizde Prevenção de Aterosclerose. Arq Bras Cardiol 2001; 77(supl. III): S4-8.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study study (4S). Lancet 1994; 344: 1383-89.
5. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose of anticoagulation on obstructive changes in saphenous-vein coronary artery disease and a broad range of initial cholesterol levels. N Engl J Med 1997; 336: 153-62.
6. Kannel WB, Wilson PWF, Larson MG, Evans JC. Coronary risk factors and coronary prevention in octogenarians. In: Wenger NK, Martin Dunitz. Ed. Cardiovascular Disease in the Octogenarian and Beyond, 1999: 141-63.
7. Sacks FM, Pfeffer MA, Moye LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average colesterol levels. Cholesterol an Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001-09.
8. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of inicial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20.5366 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 23-33.
10. Shepherd J, Blauw GJ, Murphy MB et al on behalf of the PROSPER study group. Pravastatin in the elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360: 1623-30.
11. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000; 160: 459-67.
12. Allison TG, Squires RW, Johnson BD, Gau GT. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy. Mayo Clin Proc 1999; 74: 466-73.
13. Mansur AP, Mattar APL, Tsubo CE, Simão DT, Yoshi FR, Daci K. Prescrição e aderência das estatinas em pacientes com doença arterial coronariana e hipercolesterolemia. Arq Bras Cardiol 2001; 76: 111-4
14. Ministério da Saúde. Governo do Brasil. http://www.saude.gov.br/portarias/2002